Latest articles
No of your stocks has realtime/relevant news articles that can be accessed.
Take a look into our News feed to read about recent price changes and analysis.
Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
ALTER.PADay performance
| ALTER.PA | |
|---|---|
| Price | 1.41 |
| Change Pct | -0.70 |
| Change Abs | -0.01 |
| Market Cap | 19.5 million |
| Eps | 0.03 |
| Pe Ratio | 47.00 |
| Outstanding Shares | 13.8 million |
| Volume | 422 |
| Avg Volume | 3739 |
| Industry | Medical Devices |
| Sector Name | Health Care |
| Country Short Name | FR |
| Announcement Earnings | 2023-10-11 10:59:00+00:00 |
Dividends
There is no dividend data to display. Refer our Dividend calendar for other accurate data.
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
The peer analysis is for none of your tickers available
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
ALTER.PA
Company descriptions
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing;